PARP inhibitor resistance in breast and gynecological cancer: Resistance mechanisms and combination therapy strategies

Breast cancer and gynecological tumors seriously endanger women’s physical and mental health, fertility, and quality of life. Due to standardized surgical treatment, chemotherapy, and radiotherapy, the prognosis and overall survival of cancer patients have improved compared to earlier, but the manag...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Nannan, Yang, Yan, Jin, Dongdong, Zhang, Zhenan, Shen, Ke, Yang, Jing, Chen, Huanhuan, Zhao, Xinyue, Yang, Li, Lu, Huaiwu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9455597/
https://www.ncbi.nlm.nih.gov/pubmed/36091750
http://dx.doi.org/10.3389/fphar.2022.967633

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9455597/
https://www.ncbi.nlm.nih.gov/pubmed/36091750
http://dx.doi.org/10.3389/fphar.2022.967633

Ejemplares similares